E2F-1_NN
blocks_VBZ
terminal_JJ
differentiation_NN
and_CC
causes_VBZ
proliferation_NN
in_IN
transgenic_JJ
megakaryocytes_NNS
._.

The_DT
transcription_NN
factor_NN
E2F-1_NN
plays_VBZ
a_DT
central_JJ
role_NN
in_IN
the_DT
cell_NN
cycle_NN
through_IN
its_PRP$
ability_NN
to_TO
activate_VB
genes_NNS
involved_VBN
in_IN
cell_NN
division_NN
._.

E2F-1_NN
activity_NN
is_VBZ
regulated_VBN
by_IN
a_DT
number_NN
of_IN
proteins_NNS
,_,
including_VBG
the_DT
retinoblastoma_NN
susceptibility_NN
gene_NN
product_NN
,_,
cyclin-dependent_JJ
kinases_NNS
,_,
and_CC
their_PRP$
inhibitors_NNS
,_,
proteins_NNS
that_WDT
have_VBP
been_VBN
implicated_VBN
in_IN
the_DT
control_NN
of_IN
certain_JJ
developmental_JJ
processes_NNS
._.

To_TO
investigate_VB
a_DT
potential_JJ
role_NN
of_IN
E2F-1_NN
in_IN
differentiation_NN
,_,
we_PRP
assayed_VBD
the_DT
ability_NN
of_IN
megakaryocytes_NNS
to_TO
form_VB
platelets_NNS
in_IN
an_DT
in_FW
vivo_FW
transgenic_JJ
model_NN
._.

E2F-1_NN
expression_NN
in_IN
megakaryocytes_NNS
blocked_VBD
differentiation_NN
during_IN
maturation_NN
,_,
resulting_VBG
in_IN
severe_JJ
thrombocytopenia_NN
._.

Ultrastructural_JJ
analysis_NN
of_IN
megakaryocytes_NNS
revealed_VBD
abnormal_JJ
development_NN
characterized_VBN
by_IN
hyperdemarcation_NN
of_IN
cytoplasmic_JJ
membranes_NNS
and_CC
reduced_VBD
numbers_NNS
of_IN
alpha_NN
granules_NNS
._.

Administration_NN
of_IN
megakaryocyte_NN
growth_NN
and_CC
development_NN
factor_NN
or_CC
interleukin_NN
6_CD
could_MD
not_RB
overcome_VB
the_DT
differentiation_NN
block_NN
._.

Additionally_RB
,_,
E2F-1_NN
caused_VBD
massive_JJ
megakaryocyte_NN
accumulation_NN
in_IN
both_CC
normal_JJ
and_CC
ectopic_JJ
sites_NNS
,_,
first_RB
evident_JJ
in_IN
E15_CD
embryonic_JJ
liver_NN
._.

Furthermore_RB
,_,
significant_JJ
apoptosis_NN
was_VBD
observed_VBN
in_IN
transgenic_JJ
megakaryocytes_NNS
._.

These_DT
data_NNS
indicate_VBP
that_IN
E2F-1_NN
can_MD
prevent_VB
terminal_JJ
differentiation_NN
,_,
probably_RB
through_IN
its_PRP$
cell_NN
cycle-stimulatory_JJ
activity_NN
._.

